SERUM SOLUBLE ENDOGLIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE ORGAN DYSFUNCTION SYNDROME

被引:5
作者
Atreya, Mihir R. [1 ,2 ,3 ]
Cvijanovich, Natalie Z. [4 ]
Fitzgerald, Julie C. [5 ]
Weiss, Scott L. [5 ]
Bigham, Michael T. [6 ]
Jain, Parag N. [7 ,8 ]
Schwarz, Adam J. [9 ]
Lutfi, Riad [10 ]
Nowak, Jeffrey [11 ]
Thomas, Neal J. [12 ]
Quasney, Michael [13 ]
Haileselassie, Bereketeab [14 ]
Baines, Torrey D. [15 ]
Zingarelli, Basilia [1 ,2 ,3 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH USA
[2] Cincinnati Childrens Res Fdn, Cincinnati, OH USA
[3] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[4] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[5] Childrens Hosp Philadelphia, Philadelphia, PA USA
[6] Akron Childrens Hosp, Akron, OH USA
[7] Texas Childrens Hosp, Houston, TX USA
[8] Baylor Coll Med, Houston, TX USA
[9] Childrens Hosp Orange Cty, Orange, CA USA
[10] Riley Hosp Children, Indianapolis, IN USA
[11] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA
[12] Penn State Hershey Childrens Hosp, Hershey, PA USA
[13] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI USA
[14] Lucile Packard Childrens Hosp Stanford, Palo Alto, CA USA
[15] Univ Florida Hlth, Shands Childrens Hosp, Gainesville, FL USA
来源
SHOCK | 2023年 / 60卷 / 03期
关键词
Biomarker; critical illness; endoglin; endothelial; endothelial dysfunction; multiple organ dysfunction syndrome; sepsis; septic shock; Angpt-1; angiopoietin-1; Angpt-2; angiopoietin-2; Angpt-2/Angpt-1; angiopoietin-2/angiopoietin-1; ratio; Angpt-2/Tie-2; angiopoietin-2/Tie-2; ICAM-1; intercellular adhesion molecule 1; PECAM-1; platelet endothelial cell adhesion molecule-1; sENG; soluble endoglin; sTM; soluble thrombomodulin; SEVERE SEPSIS; MORTALITY; RISK;
D O I
10.1097/SHK.0000000000002183
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Endothelial activation is a key driver of multiple organ dysfunction syndrome (MODS). Soluble endoglin (sENG) is expressed by mature and progenitor endothelial cells and thought to have angiogenic properties. We sought to determine the association between sENG and pediatric sepsis-associated MODS. Methods: Prospective observational study of pediatric septic shock. Primary outcome of interest was complicated course-a composite of death by (or) MODS on day 7 of illness. Secondary outcomes included individual organ dysfunctions. Endothelial biomarkers including sENG were measured using multiplex Luminex assays among patients with existing data on the Pediatric Sepsis Biomarker Risk Model (PERSEVERE-II) data. Multivariable regression was used to test the independent association between sENG and clinical outcomes. Serum sENG concentrations across PERSEVERE-II mortality risk strata and correlations with established markers of endothelial dysfunction were determined. Results: Three hundred six critically ill children with septic shock were included. Serum sENG concentrations were higher among those with primary and secondary outcomes of interest, with the exception of acute neurological dysfunction. Soluble endoglin was independently associated with increased odds of complicated course (adjusted odds ratio, 1.53; 95% confidence interval, 1.02-2.27; P = 0.038) and acute renal dysfunction (adjusted odds ratio, 1.84; 95% confidence interval, 1.18-2.876; P = 0.006). Soluble endoglin demonstrated graded responses across PERSEVERE-II risk strata and was positively correlated with endothelial biomarkers, except angiopoietin-1. Conclusions: Serum sENG is independently associated with complicated course and acute renal dysfunction in pediatric septic shock. Future studies are required to validate our observational data, and mechanistic studies are necessary to elucidate whether endoglin plays an organ-specific role in the development or resolution of acute renal dysfunction in sepsis.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 26 条
[1]   Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study [J].
Atreya, Mihir R. ;
Cvijanovich, Natalie Z. ;
Fitzgerald, Julie C. ;
Weiss, Scott L. ;
Bigham, Michael T. ;
Jain, Parag N. ;
Schwarz, Adam J. ;
Lutfi, Riad ;
Nowak, Jeffrey ;
Allen, Geoffrey L. ;
Thomas, Neal J. ;
Grunwell, Jocelyn R. ;
Baines, Torrey ;
Quasney, Michael ;
Haileselassie, Bereketeab ;
Lindsell, Christopher J. ;
Alder, Matthew N. ;
Wong, Hector R. .
CRITICAL CARE, 2022, 26 (01)
[2]   Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock* [J].
Atreya, Mihir R. ;
Whitacre, Brynne E. ;
Cvijanovich, Natalie Z. ;
Bigham, Michael T. ;
Thomas, Neal J. ;
Schwarz, Adam J. ;
Weiss, Scott L. ;
Fitzgerald, Julie C. ;
Allen, Geoffrey L. ;
Lutfi, Riad ;
Nowak, Jeffrey E. ;
Quasney, Michael W. ;
Shah, Amy S. ;
Wong, Hector R. .
CRITICAL CARE MEDICINE, 2020, 48 (10) :1513-1520
[3]   Pediatric Organ Dysfunction Information Update Mandate (PODIUM) Contemporary Organ Dysfunction Criteria: Executive Summary [J].
Bembea, Melania M. ;
Agus, Michael ;
Akcan-Arikan, Ayse ;
Alexander, Peta ;
Basu, Rajit ;
Bennett, Tellen D. ;
Bohn, Desmond ;
Brandao, Leonardo R. ;
Brown, Ann-Marie ;
Carcillo, Joseph A. ;
Checchia, Paul ;
Cholette, Jill ;
Cheifetz, Ira M. ;
Cornell, Timothy ;
Doctor, Allan ;
Eckerle, Michelle ;
Erickson, Simon ;
Farris, Reid W. D. ;
Faustino, E. Vincent S. ;
Fitzgerald, Julie C. ;
Fuhrman, Dana Y. ;
Giuliano, John S., Jr. ;
Guilliams, Kristin ;
Gaies, Michael ;
Gorga, Stephen M. ;
Hall, Mark ;
Hanson, Sheila J. ;
Hartman, Mary ;
Hassinger, Amanda B. ;
Irving, Sharon Y. ;
Jeffries, Howard ;
Jouvet, Philippe ;
Kannan, Sujatha ;
Karam, Oliver ;
Khemani, Robinder G. ;
Kissoon, Niranjan ;
Lacroix, Jacques ;
Laussen, Peter ;
Leclerc, Francis ;
Lee, Jan Hau ;
Leteurtre, Stephane ;
Lobner, Katie ;
McKiernan, Patrick J. ;
Menon, Kusum ;
Monagle, Paul ;
Muszynski, Jennifer A. ;
Odetola, Folafoluwa ;
Parker, Robert ;
Pathan, Nazima ;
Pierce, Richard W. .
PEDIATRICS, 2022, 149 :S1-S12
[4]   Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease [J].
Blann, A. D. ;
Brown, J. E. ;
Heitmar, R. .
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
[5]   New Medical Device Acquisition During Pediatric Severe Sepsis Hospitalizations [J].
Carlton, Erin F. ;
Donnelly, John P. ;
Hensley, Matthew K. ;
Cornell, Timothy T. ;
Prescott, Hallie C. .
CRITICAL CARE MEDICINE, 2020, 48 (05) :725-731
[6]   Circulating levels of the angiogenesis mediators endoglin, HB-EGF, BMP-9 and FGF-2 in patients with severe sepsis and septic shock [J].
Faiotto, Vanessa Boury ;
Franci, Daniel ;
Enz Hubert, Rodolfo Monteiro ;
de Souza, Gleice Regina ;
Luz Fiusa, Maiara Marx ;
Hounkpe, Bidossessi Wilfried ;
Santos, Thiago Martins ;
Carvalho-Filho, Marco Antonio ;
De Paula, Erich Vinicius .
JOURNAL OF CRITICAL CARE, 2017, 42 :162-167
[7]  
Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
[8]   Kinetics of Biomarkers of Oxidative Stress in Septic Shock: A Pilot Study [J].
Helan, Martin ;
Malaska, Jan ;
Tomandl, Josef ;
Jarkovsky, Jiri ;
Helanova, Katerina ;
Benesova, Klara ;
Sitina, Michal ;
Dastych, Milan ;
Ondrus, Tomas ;
Goldbergova, Monika Pavkova ;
Gal, Roman ;
Lokaj, Petr ;
Tomandlova, Marie ;
Parenica, Jiri .
ANTIOXIDANTS, 2022, 11 (04)
[9]   Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis [J].
Iwashyna, Theodore J. ;
Ely, E. Wesley ;
Smith, Dylan M. ;
Langa, Kenneth M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (16) :1787-1794
[10]   Sepsis-Pathophysiology and Therapeutic Concepts [J].
Jarczak, Dominik ;
Kluge, Stefan ;
Nierhaus, Axel .
FRONTIERS IN MEDICINE, 2021, 8